Since Myadm altered the expression of p21/Cip1, which is an important antiproliferative molecule, we examined whether it impacted the proliferation of PASMCs, the key to PAH-associated vascular remodeling. The gene discussed is MYADM; the disease is pulmonary arterial hypertension.